NEW YORK (GenomeWeb News) – The Swiss Foundation for Innovative New Diagnostics (FIND) has become a member of South Africa's Centre for Proteomic and Genomic Research, a non-profit organization focused on advancing translational research on "key African diseases," such as tuberculosis, HIV/AIDS, malaria, and others, CPGR and FIND said today.
The organizations will focus on developing diagnostics of value for treating these diseases.
Geneva-based FIND is focused on developing and implementing "accurate and affordable diagnostic tests that can be used as near as possible to where patients first seek care," the organizations said in a joint release.
FIND is funded by the Bill and Melinda Gates Foundation, the European Union, the Government of the Netherlands, UNITAID, Irish Aid, and other institutions and private donors.
"The opportunity to carry out high-quality, state-of-the-art genomic and proteomic research and development in Africa is very attractive since this can possibly reduce time-to-market for urgently needed diagnostic applications and could therefore create a direct benefit for the communities in Africa," Reinhard Hiller, who is CPGR's managing director, said in a statement.